Boston Trust Walden Corp Has $7.66 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Boston Trust Walden Corp cut its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,677 shares of the medical equipment provider’s stock after selling 684 shares during the period. Boston Trust Walden Corp’s holdings in Intuitive Surgical were worth $7,661,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of ISRG. Financial Life Planners bought a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $81,000. Prudent Investors Network Inc. bought a new position in Intuitive Surgical during the 4th quarter worth $290,000. Catalina Capital Group LLC lifted its holdings in shares of Intuitive Surgical by 1.7% during the fourth quarter. Catalina Capital Group LLC now owns 2,714 shares of the medical equipment provider’s stock worth $1,417,000 after buying an additional 46 shares in the last quarter. S.A. Mason LLC boosted its position in shares of Intuitive Surgical by 4.2% in the fourth quarter. S.A. Mason LLC now owns 495 shares of the medical equipment provider’s stock valued at $258,000 after acquiring an additional 20 shares during the period. Finally, Chicago Capital LLC grew its stake in shares of Intuitive Surgical by 8.2% in the fourth quarter. Chicago Capital LLC now owns 34,176 shares of the medical equipment provider’s stock valued at $17,839,000 after acquiring an additional 2,601 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the stock. Royal Bank of Canada increased their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Evercore ISI increased their target price on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Barclays raised their price objective on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Finally, Stifel Nicolaus boosted their target price on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Price Performance

Shares of ISRG opened at $578.55 on Tuesday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The stock’s fifty day moving average price is $550.40 and its two-hundred day moving average price is $510.02. The firm has a market cap of $206.07 billion, a PE ratio of 90.26, a PEG ratio of 5.51 and a beta of 1.39.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. This trade represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 28,843 shares of company stock worth $15,357,560. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.